X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with RELAXO FOOTWEARS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs RELAXO FOOTWEARS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES RELAXO FOOTWEARS AMAR REMEDIES/
RELAXO FOOTWEARS
 
P/E (TTM) x -0.5 28.9 - View Chart
P/BV x 0.1 6.7 0.9% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 AMAR REMEDIES   RELAXO FOOTWEARS
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
RELAXO FOOTWEARS
Mar-18
AMAR REMEDIES/
RELAXO FOOTWEARS
5-Yr Chart
Click to enlarge
High Rs164724 22.7%   
Low Rs86447 19.2%   
Sales per share (Unadj.) Rs261.6162.6 160.9%  
Earnings per share (Unadj.) Rs17.413.4 130.0%  
Cash flow per share (Unadj.) Rs22.317.9 124.5%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Dividend yield (eoy) %00.3 0.0%  
Book value per share (Unadj.) Rs100.763.2 159.3%  
Shares outstanding (eoy) m26.16120.35 21.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.53.6 13.3%   
Avg P/E ratio x7.243.7 16.4%  
P/CF ratio (eoy) x5.632.7 17.2%  
Price / Book Value ratio x1.29.3 13.4%  
Dividend payout %011.2 0.0%   
Avg Mkt Cap Rs m3,27070,423 4.6%   
No. of employees `000NA5.7 0.0%   
Total wages/salary Rs m1632,141 7.6%   
Avg. sales/employee Rs ThNM3,410.5-  
Avg. wages/employee Rs ThNM373.1-  
Avg. net profit/employee Rs ThNM280.7-  
INCOME DATA
Net Sales Rs m6,84419,569 35.0%  
Other income Rs m2145 47.1%   
Total revenues Rs m6,86519,614 35.0%   
Gross profit Rs m1,1313,021 37.4%  
Depreciation Rs m128543 23.6%   
Interest Rs m39886 463.3%   
Profit before tax Rs m6262,436 25.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121826 14.7%   
Profit after tax Rs m4551,611 28.2%  
Gross profit margin %16.515.4 107.1%  
Effective tax rate %19.333.9 57.0%   
Net profit margin %6.68.2 80.8%  
BALANCE SHEET DATA
Current assets Rs m4,9045,806 84.5%   
Current liabilities Rs m3,5814,335 82.6%   
Net working cap to sales %19.37.5 257.1%  
Current ratio x1.41.3 102.2%  
Inventory Days Days12459 212.2%  
Debtors Days Days10036 279.2%  
Net fixed assets Rs m1,6896,624 25.5%   
Share capital Rs m262120 217.8%   
"Free" reserves Rs m2,3587,492 31.5%   
Net worth Rs m2,6357,612 34.6%   
Long term debt Rs m507393 129.1%   
Total assets Rs m6,86212,687 54.1%  
Interest coverage x2.629.4 8.8%   
Debt to equity ratio x0.20.1 373.1%  
Sales to assets ratio x1.01.5 64.7%   
Return on assets %12.413.4 93.0%  
Return on equity %17.321.2 81.6%  
Return on capital %31.031.5 98.4%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273456 59.8%   
Fx outflow Rs m23,120 0.1%   
Net fx Rs m271-2,664 -10.2%   
CASH FLOW
From Operations Rs m-3131,543 -20.3%  
From Investments Rs m-489-1,084 45.1%  
From Financial Activity Rs m769-463 -166.1%  
Net Cashflow Rs m-33-4 833.3%  

Share Holding

Indian Promoters % 25.5 75.0 34.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 0.0 -  
FIIs % 0.0 1.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 23.9 273.2%  
Shareholders   13,061 3,357 389.1%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   ARCHIES LTD  MARICO  GODREJ INDUSTRIES  LINC PEN & PLASTICS  GILLETTE INDIA  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Indian Indices End on a Positive Note for Third Straight Day; Yes Bank Falls 5%(Closing)

Indian share markets traded on a positive note most of the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the IT sector.

Related Views on News

RELAXO FOOTWEARS Announces Quarterly Results (4QFY19); Net Profit Up 1.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, RELAXO FOOTWEARS has posted a net profit of Rs 544 m (up 1.8% YoY). Sales on the other hand came in at Rs 6 bn (up 14.2% YoY). Read on for a complete analysis of RELAXO FOOTWEARS's quarterly results.

RELAXO FOOTWEARS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 1, 2019 | Updated on Mar 1, 2019

Here's an analysis of the annual report of RELAXO FOOTWEARS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of RELAXO FOOTWEARS. Also includes updates on the valuation of RELAXO FOOTWEARS.

RELAXO FOOTWEARS Announces Quarterly Results (3QFY19); Net Profit Down 6.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, RELAXO FOOTWEARS has posted a net profit of Rs 356 m (down 6.7% YoY). Sales on the other hand came in at Rs 6 bn (up 20.5% YoY). Read on for a complete analysis of RELAXO FOOTWEARS's quarterly results.

RELAXO FOOTWEARS Announces Quarterly Results (2QFY19); Net Profit Up 23.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, RELAXO FOOTWEARS has posted a net profit of Rs 395 m (up 23.0% YoY). Sales on the other hand came in at Rs 5 bn (up 18.6% YoY). Read on for a complete analysis of RELAXO FOOTWEARS's quarterly results.

RELAXO FOOTWEARS Announces Quarterly Results (1QFY19); Net Profit Up 23.0% (Quarterly Result Update)

Aug 7, 2018 | Updated on Aug 7, 2018

For the quarter ended June 2018, RELAXO FOOTWEARS has posted a net profit of Rs 460 m (up 23.0% YoY). Sales on the other hand came in at Rs 6 bn (up 15.5% YoY). Read on for a complete analysis of RELAXO FOOTWEARS's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

A One Stock Crorepati(Profit Hunter)

Jul 4, 2019

Do you wish you could become a crorepati in the stock market? Read on...

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS